Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results

CAMBRIDGE, Mass., July 14  /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (NASDAQ:IDIX) announced today that it will report its financial results for the second quarter of 2009 on Monday, July 20, 2009 after U.S. financial markets close.

In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Monday, July 20, 2009 to discuss the company's financial results for the second quarter of 2009 and provide an update on the company's discovery and development programs.

To access the call please dial 800-774-5358 U.S./Canada or 706-758-9475 International and enter passcode 20088902 or to listen to a live webcast and view accompanying slides, go to "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/. A replay of the call will also be available from 6:30 p.m. ET on July 20, 2009 until August 3, 2009 12:00 a.m. ET.  To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 20088902. An archived webcast will also be available for two weeks after the call on the Idenix website.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com/.

Amy Sullivan 617-995-9838 (investors)

Teri Dahlman 617-995-9905 (media) 

DATASOURCE: Idenix Pharmaceuticals, Inc.



CONTACT:  Investors, Amy Sullivan, [phone], or Media, Teri

Dahlman, [phone], both of Idenix Pharmaceuticals, Inc.



Web Site:  http://www.idenix.com/ 

Copyright